Novo Nordisk has announced the launch of a daily oral pill version of its weight-loss injection, Wegovy, just two weeks after the new formulation was approved by regulators
Manufacturers must accelerate price reductions to improve coverage, but PBMs and insurers share blame
By prioritizing these tools, we empower patients with knowledge about their health, fostering trust and collaboration
Hims & Hers didnt respond to Healthcare Brews request for comment by publication
Regulatory Considerations Sermorelin is classified as a prescription medication and regulated by health authorities in many countries
It gives two examples: oral semaglutide costs more than the injection but suits people with needle anxiety, and tirzepatide costs more than semaglutide but offers dual GIP and GLP-1 signaling that may be more efficient per dollar for some patients